Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bieligk, S. C.
Right arrow Articles by Coit, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bieligk, S. C.
Right arrow Articles by Coit, D. G.

Annals of Surgical Oncology, Vol 6, Issue 3 232-240, Copyright © 1999 by Society of Surgical Oncology


ARTICLES

Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes

S. C. Bieligk, R. Ghossein, S. Bhattacharya and D. G. Coit
Department of Surgery, University of Texas Southwestern Medical Center at Dallas, 75235-9155, USA.

BACKGROUND: Sentinel lymph node (SLN) biopsy is an alternative to elective dissection or observation for management of lymph node basins in patients with cutaneous melanomas. The detection of tyrosinase mRNA in melanoma SLN specimens by reverse transcription-polymerase chain reaction (RT-PCR) has been reported to be a more sensitive method to detect subclinical metastases, compared with histological analysis. The aims of this study were to (1) define the yield of RT-PCR in assessing SLNs, compared with histological analysis, (2) identify the incidence of false-positive results in SLNs, and (3) report the rate of actin PCR negativity (i.e., samples with degraded RNA) in SLNs. METHODS: Twenty-eight patients with 1.2-9.6-mm cutaneous melanomas underwent SLN biopsy (between October 1996 and March 1997). One half of each SLN was analyzed by nested RT-PCR for tyrosinase mRNA. The other half of the SLN was examined by routine microscopy. Twenty-one lymph nodes from patients without melanoma were evaluated as controls. RESULTS: Two of the 28 patients with melanoma were excluded because of RNA degradation, as indicated by actin negativity. Six of the remaining 26 patients exhibited melanoma metastases in routine histological examinations. All histologically positive lymph nodes were RT-PCR-positive. Thirteen of the 20 (65%) histologically negative cases were RT-PCR-positive. Of 21 control lymph nodes, 3 were actin-negative and were not assessable for tyrosinase mRNA. Two of the remaining 18 (11%) negative-control nodes were RT-PCR-positive. CONCLUSIONS: Among patients undergoing SLN biopsy, tyrosinase mRNA was detectable in 73% of SLNs from patients at risk for regional nodal metastases, including all of those with histologically positive SLNs. There is a definable false-positive rate for tyrosinase mRNA detection in the lymph nodes of patients who do not have melanoma. Actin verification of RNA integrity is necessary to ensure the accuracy of this test in detecting tyrosinase mRNA. Ongoing follow-up monitoring will define the prognostic value of this assay.


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
M G Cook and S Di Palma
Pathology of sentinel lymph nodes for melanoma
J. Clin. Pathol., August 1, 2008; 61(8): 897 - 902.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
K. P. White, C. I. Barry, and J. W. Patterson
Focus-Floating Microscopy for Detecting Borrelia Species in Tissue Sections: Back to Basics
Arch Dermatol, May 1, 2008; 144(5): 662 - 663.
[Full Text] [PDF]


Home page
Arch SurgHome page
T. G. Zogakis, R. Essner, H.-j. Wang, R. R. Turner, Y. T. Takasumi, R. L. Gaffney, J. H. Lee, and D. L. Morton
Melanoma Recurrence Patterns After Negative Sentinel Lymphadenectomy
Arch Surg, September 1, 2005; 140(9): 865 - 872.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Ulmer, J. R. Fischer, S. Schanz, K. Sotlar, H. Breuninger, K. Dietz, G. Fierlbeck, and C. A. Klein
Detection of Melanoma Cells Displaying Multiple Genomic Changes in Histopathologically Negative Sentinel Lymph Nodes
Clin. Cancer Res., August 1, 2005; 11(15): 5425 - 5432.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. N. Abrahamsen, B. Sandahl Sorensen, E. Nexo, S. J. Hamilton-Dutoit, J. Larsen, and T. Steiniche
Pathologic Assessment of Melanoma Sentinel Nodes: A Role for Molecular Analysis Using Quantitative Real-Time Reverse Transcription-PCR for MART-1 and Tyrosinase Messenger RNA
Clin. Cancer Res., February 15, 2005; 11(4): 1425 - 1433.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
U. S. Kammula, R. Ghossein, S. Bhattacharya, and D. G. Coit
Serial Follow-Up and the Prognostic Significance of Reverse Transcriptase-Polymerase Chain Reaction--Staged Sentinel Lymph Nodes From Melanoma Patients
J. Clin. Oncol., October 1, 2004; 22(19): 3989 - 3996.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Kawada, M. Sonoshita, H. Sakashita, A. Takabayashi, Y. Yamaoka, T. Manabe, K. Inaba, N. Minato, M. Oshima, and M. M. Taketo
Pivotal Role of CXCR3 in Melanoma Cell Metastasis to Lymph Nodes
Cancer Res., June 1, 2004; 64(11): 4010 - 4017.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
T. M. Pawlik, M. I. Ross, and J. E. Gershenwald
Lymphatic Mapping in the Molecular Era
Ann. Surg. Oncol., April 1, 2004; 11(4): 362 - 374.
[Full Text] [PDF]


Home page
JCOHome page
C. T. Kuo, D. S.B. Hoon, H. Takeuchi, R. Turner, H.-J. Wang, D. L. Morton, and B. Taback
Prediction of Disease Outcome in Melanoma Patients by Molecular Analysis of Paraffin-Embedded Sentinel Lymph Nodes
J. Clin. Oncol., October 1, 2003; 21(19): 3566 - 3572.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K. J. Busam
Advances in Molecular Staging of Melanoma Patients: Multimarker Analysis of Archival Lymph Node Tissue
J. Clin. Oncol., October 1, 2003; 21(19): 3550 - 3551.
[Full Text] [PDF]


Home page
Mol. Pathol.Home page
V Davids, S H Kidson, and G S Hanekom
Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate
Mol. Pathol., February 1, 2003; 56(1): 43 - 51.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. Mariani, M. Gipponi, L. Moresco, G. Villa, M. Bartolomei, G. Mazzarol, M. C. Bagnara, A. Romanini, F. Cafiero, G. Paganelli, et al.
Radioguided Sentinel Lymph Node Biopsy in Malignant Cutaneous Melanoma*
J. Nucl. Med., June 1, 2002; 43(6): 811 - 827.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
H. E. Wiley, E. B. Gonzalez, W. Maki, M.-t. Wu, and S. T. Hwang
Expression of CC Chemokine Receptor-7 and Regional Lymph Node Metastasis of B16 Murine Melanoma
J Natl Cancer Inst, November 7, 2001; 93(21): 1638 - 1643.
[Abstract] [Full Text] [PDF]


Home page
ImagingHome page
P J Ell
A revolution in surgical oncology: sentinel lymph node biopsy
Imaging, September 1, 2001; 13(3): 197 - 205.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. A. Ghossein, S. Bhattacharya, and J. Rosai
Molecular Detection of Micrometastases and Circulating Tumor Cells in Solid Tumors
Clin. Cancer Res., August 1, 1999; 5(8): 1950 - 1960.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Society of Surgical Oncology.